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Aims: BODE (body mass index, airﬂow obstruction, dyspnea, exercise capacity)
index predicts mortality in chronic obstructive pulmonary diseases. The purpose of
this study was determine the relationship between BODE index, functional health
status, respiratory muscle strength, and functional capacity in patients with cystic
ﬁbrosis (CF).
Methods: Thirty one patients with CF, aged 7−24 years, (mean FEV1 = 76.71
±26.86%, 14M, 17F) were included in the study. Pulmonary function test, res-
piratory muscle strength (MIP and MEP) and six minute walk test (6MWT)
were measured. Heart rate, respiratory rate, oxygen saturation (SpO2), dyspnea
and fatigue perception (modiﬁed Borg scale) were evaluated before and after the
6MWT. Disease severity was determined by the Shwachman score. BODE index
was calculated. The Childhood Health Assessment Questionnaire (CHAQ) with
disability index, discomfort index, and health status index subscales was used.
Results: BODE index was signiﬁcantly related with Shwachman score (r = −0.446,
p = 0.029), discomfort index (r = 0.504, p = 0.017), health status index (r = 0.593,
p = 0.004), MIP (r = −0.484, p = 0.006), MEP (r = −0.453, p = 0.011), exercise heart
rate (r = 0.454, p = 0.01), exercise SpO2 (r = −0.606, p< 0.0001), exercise respiratory
rate (r = 0.515, p = 0.014), and fatigue perception (r = 0.588, p = 0.001).
Conclusions: BODE index is related to disease severity, discomfort and health
status index, respiratory muscle strength and physiologic parameters of exercise.
BODE index can be used to predict mortality in CF patients.
279 Beneﬁts of aromatherapy massage for adult cystic ﬁbrosis
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Introduction: Aromatherapy massage continues to gain in popularity as people
become more aware of the importance of de-stressing the mind and body. Some
adult cystic ﬁbrosis patients experience lack of control over certain aspects of their
life; deterioation in their health can have negative effects on their independence,
quality of life and psychological well being. With this in mind we started a
pilot study to offer aromatherapy massage in conjunction with airway clearance
techniques to some patients as part of the community physiotherapy service.
Method: 6 patients who are in the terminal stage of their illness, waiting on the lung
transplant list or experiencing a particularly stressful time were offered a course of
aromatherapy massage in conjunction with their usual airway clearance treatment.
Essential oils were selected to suit the individual and these were massaged into the
upper back and shoulders using remedial massage techniques. The massage was
then followed by the patient’s usual airway clearance regime.
Outcome: All patients reported that they felt relaxed and calm following the
combined session. Some patients felt that they cleared their secretions more easily
and with less effort than usual. Other comments included that they felt that their
chest was clearer and felt lighter.
Conclusions: Preliminary ﬁndings from this small pilot study suggest that a course
of aromatherapy may be useful for some groups of patients. Careful selection criteria
and further evaluation is required.
